C. N. Ramchand

Biography

Dr. C.N. Ramchand is the CEO of Saksin Lifesciences and has a strong expertise in drug discovery and research, and has had a highly successful career across India, EU and the US. Prior to joining Saksin, Dr Ramchand was the CEO of Laila Pharmaceuticals and a Director at KEMIN Pharma India (a subsidiary of Kemin Pharma Belgium BVBA) and was simultaneously holding a position as Director of Research and Development, Kemin Industries South Asia Pvt. Ltd (a part of Kemin Industries Inc., Demoines, USA). In addition, Dr Ramchand was also a global executive team member of Kemin Industries. Dr. Ramchand holds a PhD in Biochemistry from MS University Baroda. He also served as assistant professor from 1982-84 at MS University. He has also obtained his M Phil from the same University. He holds a Masters degree in Chemistry from the University of Kerala. He is also the 3 time winner of the Young Scientist award from Charing Cross and Westminster Medical School, UK for the work of the role of membrane pathology in schizophrenia and the development of EPA as a therapy for schizophrenia. He has extensive experience in basic research activities having handled prestigious projects in the US and UK, both at Universities and Pharma Industries. He has over 25 years of rich experience in the areas of teaching, basic research, drug discovery programs , study of disease mechanisms, guiding M Sc. / Ph D. students and setting up a Research facility. Prior to the assignment at Kemin Industries, Dr Ramchand served as Vice President and Head of Drug Discovery Research (1999-2004) at Sun Pharmaceuticals Industries- the largest Pharma company in India (currently No 1 in-terms of market capitalization). He was closely involved in setting up a multi million dollar Drug Discovery center including design and development of laboratories. He had developed 3 molecules while at Sun Pharma which are currently in Phase II trials. He has also held the position of Joint Coordinator and Head of the Laboratory research program in Biomedical sciences, University of Sheffield and Northern General Hospital Sheffield, UK (1994-1999)- a prestigious University Position. Prior to this, he was the Sr. Scientist and Project Head at Institute of Biological Psychiatry at University of Wales, Bangor UK (1990-1994). He has also worked as Senior Research Officer at the Biochemistry Department, University of North Wales, Bangor, UK (1987-1990). Prior to this he was also a postdoctoral fellow at University of South Carolina, USA (1984-1987). Dr. Ramchand has published over 70 peer-reviewed papers in international journals, edited 5 books ( he’s currently writing two books on drug discovery with Tata McGraw Hill) and has applied for over 10 patents. He has made over 100 research presentations at international conferences world wide and is also currently a Sr. Visiting fellow at the University of Sheffield and University of New Castle Upon-Tyne, UK, and at the Slovakian Academy of Sciences, Slovak Republic. He has a very close research association with State University of New York at Buffalo, USA and Florida International University (Miami, USA) and also is an adjunct faculty and PhD advisor at the MS University of Baroda. Currently, Dr Ramchand is an Honorary Visiting Professor to European Nanotechnology consortium at University of Newcastle at UK. Dr. C.N. Ramchand is the CEO of Saksin Lifesciences and has a strong expertise in drug discovery and research, and has had a highly successful career across India, EU and the US. Prior to joining Saksin, Dr Ramchand was the CEO of Laila Pharmaceuticals and a Director at KEMIN Pharma India (a subsidiary of Kemin Pharma Belgium BVBA) and was simultaneously holding a position as Director of Research and Development, Kemin Industries South Asia Pvt. Ltd (a part of Kemin Industries Inc., Demoines, USA). In addition, Dr Ramchand was also a global executive team member of Kemin Industries. Dr. Ramchand holds a PhD in Biochemistry from MS University Baroda. He also served as assistant professor from 1982-84 at MS University. He has also obtained his M Phil from the same University. He holds a Masters degree in Chemistry from the University of Kerala. He is also the 3 time winner of the Young Scientist award from Charing Cross and Westminster Medical School, UK for the work of the role of membrane pathology in schizophrenia and the development of EPA as a therapy for schizophrenia. He has extensive experience in basic research activities having handled prestigious projects in the US and UK, both at Universities and Pharma Industries. He has over 25 years of rich experience in the areas of teaching, basic research, drug discovery programs , study of disease mechanisms, guiding M Sc. / Ph D. students and setting up a Research facility. Prior to the assignment at Kemin Industries, Dr Ramchand served as Vice President and Head of Drug Discovery Research (1999-2004) at Sun Pharmaceuticals Industries- the largest Pharma company in India (currently No 1 in-terms of market capitalization). He was closely involved in setting up a multi million dollar Drug Discovery center including design and development of laboratories. He had developed 3 molecules while at Sun Pharma which are currently in Phase II trials. He has also held the position of Joint Coordinator and Head of the Laboratory research program in Biomedical sciences, University of Sheffield and Northern General Hospital Sheffield, UK (1994-1999)- a prestigious University Position. Prior to this, he was the Sr. Scientist and Project Head at Institute of Biological Psychiatry at University of Wales, Bangor UK (1990-1994). He has also worked as Senior Research Officer at the Biochemistry Department, University of North Wales, Bangor, UK (1987-1990). Prior to this he was also a postdoctoral fellow at University of South Carolina, USA (1984-1987). Dr. Ramchand has published over 70 peer-reviewed papers in international journals, edited 5 books ( he’s currently writing two books on drug discovery with Tata McGraw Hill) and has applied for over 10 patents. He has made over 100 research presentations at international conferences world wide and is also currently a Sr. Visiting fellow at the University of Sheffield and University of New Castle Upon-Tyne, UK, and at the Slovakian Academy of Sciences, Slovak Republic. He has a very close research association with State University of New York at Buffalo, USA and Florida International University (Miami, USA) and also is an adjunct faculty and PhD advisor at the MS University of Baroda. Currently, Dr Ramchand is an Honorary Visiting Professor to European Nanotechnology consortium at University of Newcastle at UK.

Research Interest

Pharmaceutical sciences